Added: Keonia Humes - Date: 22.09.2021 03:00 - Views: 10419 - Clicks: 4316
From today, Australians aged 50 or older are eligible to receive their COVID vaccine from special respiratory clinics or mass vaccination hubs in some states. Appointments with selected GPs are available from May However, a recent poll shows many people over 50 are hesitant to get vaccinated, particularly with the AstraZeneca vaccine earmarked for them.
Clinical trials, which have included more than 57, people to datefound the AstraZeneca vaccine to be safe and effective. In clinical trials, adults aged and those older than 55 had similar immune responses. However, there have been some concerns about protection against the B. We still need more long-term data to say for certain whether the vaccine prevents transmission of COVID However, preliminary UK research provides some welcome news. Researchers looked at more thanhouseholds and nearly one million contacts of COVID cases. This is great news in terms of slowing the spread of the disease.
Both clinical trials and real-world data confirm the AstraZeneca vaccine has a good safety profile similar to other vaccines commonly used in Australia. Side-effects are common and are mostly mild to moderate, with few recipients needing medical attention. The most common are reactions at the injection site, 50 and older, headache and muscle pain. These occur in half to three-quarters of people under 55 after their first dose, and are less common in older people.
The side-effects generally start within 24 hours and last around one or two days, and indicate your immune 50 and older is working. But how will we know they're safe? This is a very rare condition in which blood clots thrombosis and low levels of platelets thrombocytopenia occur days after receiving the vaccine.
About six in every million people vaccinated with the AstraZeneca vaccine develop the condition.
And it tends to be more common 50 and older people under Other than younger age, there are no other risk factors for these clots we know of yet. In Australia, there have been six cases of this type of blood clotting : one person in their 30s, four in their 40s, and one in their 80s. Of these, a person in their 40s has died from it. : What is thrombocytopenia, the rare blood condition possibly linked to the AstraZeneca vaccine?
The risk-benefit analysis for Australians right now differs depending on 50 and older amount of COVID in the community, your age and the availability of alternative vaccines. Based on a small amount of data so far, the risk of these blood clots after the AstraZeneca vaccine, for people aged is about 0. But the risk of getting severe COVID or the risk of admission into intensive care from COVID is much higher for the over 50s — nearly ten-fold higher than the risk of clots after the vaccine. There are different risk-benefit calculations for different scenarios. Australia has almost no disease in the community.
However, this could change very quickly if there were new outbreaks.
We also have no alternative to the AstraZeneca vaccine for most people over 50 more Pfizer vaccine is not available until the last quarter of So balancing the risks and benefits of the vaccineis extremely challenging. People may not perceive their risk of COVID as high enough to 50 and older vaccination and are preferring to wait, perhaps six months or more until other vaccines are available. Vaccination will contribute to the prevention of long COVID symptoms that linger for months as well as increased ability to move around freely in society, including being able to attend large events.
Vaccination will help us avoid lockdowns or school closures, allow us to travel overseas and return to normal life. : A balancing act between benefits and risks: making sense of the latest vaccine news. This will give you details of the state- and territory-run vaccination clinics near you that are open from today not all are taking appointments for the over 50s yet.
From May 17, you can receive your vaccine at 50 and older GP clinics. Two doses of the AstraZeneca vaccine are needed for best protection, preferably 12 weeks apart. Plymouth Contemporary — Plymouth, Devon. Edition: Available editions United Kingdom.50 and older
email: [email protected] - phone:(532) 988-5149 x 3949
People 50 and older eligible to be vaccinated beginning March 15